Full Name
H. Phillip Koeffler
Variants
Phillip Koeffler, H.
Koeffler Philip H.
Koeffler H.P.
Koeffler, H.P.
 
Main Affiliation
 
 
Email
mdchpk@nus.edu.sg
 
 

Publications

Results 21-40 of 94 (Search time: 0.019 seconds).

Issue DateTitleAuthor(s)
21Jun-2010Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancerIwanski, G.B.; Lee, D.H.; En-Gal, S.; Doan, N.B.; Castor, B.; Vogt, M.; Toh, M.; Bokemeyer, C.; Said, J.W.; Thoennissen, N.H.; Koeffler, H.P. 
2228-Aug-2012Cutaneous Papilloma and Squamous Cell Carcinoma Therapy Utilizing Nanosecond Pulsed Electric Fields (nsPEF)Yin, D.; Yang, W.G.; Weissberg, J.; Goff, C.B.; Chen, W.; Kuwayama, Y.; Leiter, A.; Xing, H.; Meixel, A.; Gaut, D.; Kirkbir, F.; Sawcer, D.; Vernier, P.T.; Said, J.W.; Gundersen, M.A.; Koeffler, H.P. 
2328-Jan-2014Deficiency of CCAAT/enhancer binding protein-epsilon reduces atherosclerotic lesions in LDLR-/- MiceOkamoto, R.; Gery, S.; Gombart, A.F.; Wang, X.; Castellani, L.W.; Akagi, T.; Chen, S.; Arditi, M.; Ho, Q.; Lusis, A.J.; Li, Q.; Koeffler, H.P. 
241-Aug-2010Deregulated intracellular signaling by mutated c-CBL in myeloid neoplasmsOgawa, S.; Shih, L.-Y.; Suzuki, T.; Otsu, M.; Nakauchi, H.; Koeffler, H.P. ; Sanada, M.
2523-Feb-2012Dominant-negative mechanism of leukemogenic PAX5 fusionsKawamata, N.; Pennella, M.A.; Woo, J.L.; Berk, A.J.; Koeffler, H.P. 
26Feb-2014Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474)Lin, L.; Gaut, D.; Hu, K.; Yan, H.; Yin, D.; Koeffler, H.P. 
27Apr-2012Effect of dasatinib against thyroid cancer cell lines in vitro and a xenograft model in vivoChan, D.; Tyner, J.W.; Chng, W.J. ; Bi, C.; Okamoto, R.; Said, J.; Ngan, B.D.; Braunstein, G.D.; Koeffler, H.P. 
282020EWS-FLI1 regulates and cooperates with core regulatory circuitry in Ewing sarcomaShi, X.; Zheng, Y.; Jiang, L.; Zhou, B.; Yang, W.; Li, L.; Ding, L. ; Huang, M.; Gery, S.; Lin, D.-C.; Koeffler, H.P. 
292007Expression of Cyr61, CTGF, and WISP-1 Correlates with Clinical Features of Lung CancerChen P.-P.; Li W.-J.; Wang Y.; Zhao S.; Li D.-Y.; Feng L.-Y.; Shi X.-L.; Koeffler H.P. ; Tong X.-J.; Xie D.
3015-Nov-2011Expression of p-JAK2 predicts clinical outcome and is a potential molecular target of acute myelogenous leukemiaIkezoe, T.; Kojima, S.; Furihata, M.; Yang, J.; Nishioka, C.; Takeuchi, A.; Isaka, M.; Koeffler, H.P. ; Yokoyama, A.
312015FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasionZheng, Y; Guo, J; Zhou, J; Lu, J; Chen, Q; Zhang, C; Qing, C; Koeffler, H.P ; Tong, Y
326-Oct-2011Frequent pathway mutations of splicing machinery in myelodysplasiaYoshida, K.; Sanada, M.; Shiraishi, Y.; Nowak, D.; Nagata, Y.; Yamamoto, R.; Sato, Y.; Sato-Otsubo, A.; Kon, A.; Nagasaki, M.; Chalkidis, G.; Suzuki, Y.; Shiosaka, M.; Kawahata, R.; Yamaguchi, T.; Otsu, M.; Obara, N.; Sakata-Yanagimoto, M.; Ishiyama, K.; Mori, H.; Nolte, F.; Hofmann, W.-K.; Miyawaki, S.; Sugano, S.; Haferlach, C.; Koeffler, H.P. ; Shih, L.-Y.; Haferlach, T.; Chiba, S.; Nakauchi, H.; Miyano, S.; Ogawa, S.
33Aug-2013Genetic differences between Asian and Caucasian chronic lymphocytic leukemiaKawamata, N.; Moreilhon, C.; Saitoh, T.; Karasawa, M.; Bernstein, B.K.; Sato-Otsubo, A.; Ogawa, S.; Raynaud, S.; Koeffler, H.P. 
342015Genomic landscape of liposarcomaKanojia, D ; Nagata, Y; Garg, M ; Lee, D.H ; Sato, A; Yoshida, K; Sato, Y; Sanada, M; Mayakonda, A ; Bartenhagen, C; Klein, H.-U; Doan, N.B; Said, J.W; Mohith, S; Gunasekar, S; Shiraishi, Y; Chiba, K; Tanaka, H; Miyano, S; Myklebost, O; Yang, H ; Dugas, M; Meza-Zepeda, L.A; Silberman, A.W; Forscher, C; Tyner, J.W; Ogawa, S; Phillip Koeffler, H 
35Sep-2010Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemiaOkamoto, R.; Ogawa, S.; Nowak, D.; Kawamata, N.; Akagi, T.; Kato, M.; Sanada, M.; Weiss, T.; Haferlach, C.; Dugas, M.; Ruckert, C.; Haferlach, T.; Phillip Koeffler, H. 
362015H-ferritin is preferentially incorporated by human erythroid cells through transferrin receptor 1 in a threshold-dependent mannerSakamoto S.; Kawabata H.; Masuda T.; Uchiyama T.; Mizumoto C.; Ohmori K.; Koeffler H.P. ; Kadowaki N.; Takaori-Kondo A.
372011Hematological malignancyOkamoto, R.; Koeffler, H.P. 
3829-Nov-2018Identification of a Novel CEBPE Enhancer Essential for Granulocytic DifferentiationShyamsunder, Pavithra ; Shanmugasundaram, Mahalakshmi; Mayakonda, Anand ; Teoh, Weoi Woon ; Han, Lin; Lim, Mei Chee ; Fullwood, Melissa ; An, Omer ; Yang, Henry ; Shi, Jizhong ; Hossain, Md Zakhir ; Madan, Vikas ; Koeffler, H Phillip 
395-Apr-2019Identification of a novel enhancer of CEBPE essential for granulocytic differentiation.Shyamsunder, Pavithra ; Shanmugasundaram, Mahalakshmi; Mayakonda, Anand ; Dakle, Pushkar ; Teoh, Weoi Woon ; Han, Lin; Kanojia, Deepika ; Lim, Mei Chee ; Fullwood, Melissa ; An, Omer ; Yang, Henry ; Jizhong, Shi ; Hossain, Md Zakir ; Madan, Vikas ; Koeffler, H Phillip 
402017Identification of a novel SYK/c-MYC/MALAT1 signaling pathway and its potential therapeutic value in Ewing sarcomaSun, H; Lin, D.-C ; Cao, Q; Pang, B ; Gae, D.D; Lee, V.K.M ; Lim, H.J; Doan, N; Said, J.W; Gery, S; Chow, M; Mayakonda, A ; Forscher, C; Tyner, J.W; Koeffler, H.P